PRESS RELEASE – Aurora Hashish Inc., the Canadian world medical hashish firm, has introduced that Simona King, a former government of Bristol Myers-Squibb, a number one multinational pharmaceutical firm, has been appointed as Chief Monetary Officer (CFO) of the corporate since February. . 21, 2024.

King brings greater than 25 years of progressive monetary management expertise, with deep enterprise information and confirmed success with world and rising organizations. He served almost 20 years with Bristol Myers-Squibb, the place he held more and more senior monetary roles and enabled the corporate's development technique.

Glen Ibbott, present CFO, will step down from his full-time position efficient February 20 to pursue new alternatives. He’ll stay in an advisory position over the subsequent few months to make sure a clean transition of duties to King.

CFO transition

“As our firm continues to evolve, we’re excited to welcome Simona King to Aurora,” stated CEO Miguel Martin. “Simona has spent her profession rising companies, enhancing operational effectivity, and main a world-class monetary group. Her deep operational and monetary information, mixed along with her intensive expertise in a number of company capabilities and deep dedication to expertise growth, make her uniquely positioned to assist information Aurora in its subsequent part of development.”

Martin added: “On behalf of our board of administrators, and the complete Aurora group, I want to provide our honest thanks and appreciation to Glen. Since 2017, Glen has devoted immeasurable time, power and keenness to constructing Aurora into a number one medical hashish firm; and we now have been lucky to have his management over time as we navigated this rising trade. We want him all one of the best in his future endeavors.”

King brings deep monetary experience in company, operational and worldwide models. In recent times, he has expanded his skilled attain, becoming a member of fast-growing public firms in rising sectors, together with biotechnology. He joins Aurora most just lately as CFO of quite a lot of clinical-stage biotech firms.

Share Consolidation

Aurora additionally introduced the completion of its beforehand introduced consolidation of the corporate's widespread inventory on a ten to 1 foundation. The widespread inventory will start buying and selling on a post-consolidation foundation on the Nasdaq inventory market and the Toronto Inventory Change below the image “ACB” on the opening of buying and selling on February 20.

Source link